← Back to Patent Explorer
US4148994A Expired / Lapsed US ⏱️ 0.0 years remaining

Crystalline metal salts of β-nicotinamide-adenine-dinucleotide

Assignee: Roche Diagnostics GmbH
•
Filing: 1976-12-27
•
Granted: 1979-04-10
•
Expires: 1996-12-27
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Crystalline salts of β-nicotinamide-adenine-dinucleotide (β-NAD), particularly alkali metal salts thereof are prepared in good yield and high quality to provide an analytically useful β-NAD form.

Inventors

  • 👤 Klaus Muhlegger
  • 👤 Gunter Weimann
  • 👤 Michael Nelboeck-Hochstetter

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-28 11:41
CPC Classifications
C; C07; C07H; C07H19/00; C07H19/02; C07H19/04; C07H19/16; C07H19/20; C07H19/207

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 33 words
Orhtorhombic monolithium salt of beta-nicotinamide-adenine-dinucleotide hydrate with the following characteristics: the space group P2 1 2 1 2 1 , the cell dimensions a=10.073±0.003 A, b=15.839±0.004 A, c=17.821±0.004 A, and the angles alpha=beta=gamma=90°.
Claim 2
Dependent Claim 33 words
Orhtorhombic monolithium salt of beta-nicotinamide-adenine-dinucleotide hydrate with the following characteristics: the space group P2 1 2 1 2 1 , the cell dimensions a=10.073±0.003 A, b=15.839±0.004 A, c=17.821±0.004 A, and the angles alpha=beta=gamma=90°.

References Cited (Backward Citations)

US3429868A Cited
US3749709A Cited
US3700654A Cited
US3787392A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1982-04-09 1982-10-09 1983-04-10 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1986-04-09 1986-10-09 1987-04-10 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1990-04-09 1990-10-09 1991-04-10 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag